Drug profile · INN
esomeprazole strontium
ESOMEPRAZOLE STRONTIUM
esomeprazole strontium (ESOMEPRAZOLE STRONTIUM) is a potassium-transporting atpase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — esomeprazole strontium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
esomeprazole strontium (ESOMEPRAZOLE STRONTIUM) is a potassium-transporting atpase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Potassium-transporting ATPase inhibitor
Primary target: Potassium-transporting ATPase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is esomeprazole strontium?
esomeprazole strontium (ESOMEPRAZOLE STRONTIUM) is a potassium-transporting atpase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for esomeprazole strontium?
ESOMEPRAZOLE STRONTIUM is a marketed brand name for esomeprazole strontium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of esomeprazole strontium?
esomeprazole strontium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.